Effect of ethyl acetate extract from Usnea longissima on chemotherapy-associated multiple organ dysfunction in rats

ArticleAçık Erişim

Özet

Background: The toxic effects of doxorubicin and cisplatin in various organs have been associated with oxidative stress. Studies have shown that Usnea longissima has strong antioxidant effects. This study aimed to investigate the protective effect of ethyl acetate extract from Usnea longissima (ULE), which is known to have strong antioxidant effects, on chemotherapeutic-induced heart, kidney, liver, and ovarian toxicity. Methods: Albino Wistar female rats were divided into five groups (12 rats per group): healthy (HG), doxorubicin (DOX), Cisplatin (CIS), Doxorubicin+ ULE (DULE), Cisplatin+ ULE (CULE). In this experiment, ULE was given 100 mg/kg orally. After 1 hour, 2.5 mg/kg doxorubicin and 2.5 mg/kg cisplatin were administered intraperitoneally. Drug treatments continued once a day for seven days. At the end of seven days, six rats from each group were euthanized and heart, kidney, liver, and ovary tissues were analyzed biochemically. The remaining rats were left in the laboratory with male rats for 45 days for reproduction. Results: ULE inhibited chemotherapeutic-induced increase in malondialdehyde, tumor necrosis factor-alpha, and interleukin 6 and a decrease in total glutathione in liver, kidney, and ovarian tissues. ULE also inhibited the increase of blood urea nitrogen, creatinine, alanine aminotransferase, and aspartate aminotransferase in serum. ULE treatment had no protective effect against doxorubicin and cisplatin cardiac toxicity. On the other hand, ULE also decreased the delay in pregnancy induced by chemotherapy. Conclusion: ULE may be considered an adjuvant therapy in patients receiving chemotherapy to reduce liver, kidney, and ovarian toxicity. © 2024

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11202Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorBingul, Eda
dc.contributor.authorBulut, Seval
dc.contributor.authorMammadov, Renad
dc.contributor.authorCicek, Betul
dc.contributor.authorDogru, Tugba Erkmen
dc.contributor.authorSuleyman, Halis
dc.contributor.authorMendil, Ali Sefa
dc.date.accessioned2026-10-18T20:26:17.313555942Z
dc.date.available2026-10-18T20:26:17.313555942Z
dc.date.issued2024
dc.description.abstractBackground: The toxic effects of doxorubicin and cisplatin in various organs have been associated with oxidative stress. Studies have shown that Usnea longissima has strong antioxidant effects. This study aimed to investigate the protective effect of ethyl acetate extract from Usnea longissima (ULE), which is known to have strong antioxidant effects, on chemotherapeutic-induced heart, kidney, liver, and ovarian toxicity. Methods: Albino Wistar female rats were divided into five groups (12 rats per group): healthy (HG), doxorubicin (DOX), Cisplatin (CIS), Doxorubicin+ ULE (DULE), Cisplatin+ ULE (CULE). In this experiment, ULE was given 100 mg/kg orally. After 1 hour, 2.5 mg/kg doxorubicin and 2.5 mg/kg cisplatin were administered intraperitoneally. Drug treatments continued once a day for seven days. At the end of seven days, six rats from each group were euthanized and heart, kidney, liver, and ovary tissues were analyzed biochemically. The remaining rats were left in the laboratory with male rats for 45 days for reproduction. Results: ULE inhibited chemotherapeutic-induced increase in malondialdehyde, tumor necrosis factor-alpha, and interleukin 6 and a decrease in total glutathione in liver, kidney, and ovarian tissues. ULE also inhibited the increase of blood urea nitrogen, creatinine, alanine aminotransferase, and aspartate aminotransferase in serum. ULE treatment had no protective effect against doxorubicin and cisplatin cardiac toxicity. On the other hand, ULE also decreased the delay in pregnancy induced by chemotherapy. Conclusion: ULE may be considered an adjuvant therapy in patients receiving chemotherapy to reduce liver, kidney, and ovarian toxicity. © 2024
dc.identifier.doi10.1016/j.biopha.2024.117636
dc.identifier.issn0753-3322
dc.identifier.pmid39489120
dc.identifier.scopus2-s2.0-85207871659
dc.identifier.startpage117636
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11202
dc.identifier.volume181
dc.language.isoen
dc.publisherElsevier Masson s.r.l.
dc.relation.ispartofBiomedicine and Pharmacotherapy
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCisplatin
dc.subjectDoxorubicin
dc.subjectToxicity
dc.subjectUsnea longissima extract
dc.subjectAcetates
dc.subjectAnimals
dc.subjectAntineoplastic Agents
dc.subjectAntioxidants
dc.subjectFemale
dc.subjectKidney
dc.subjectLiver
dc.subjectMale
dc.subjectMultiple Organ Failure
dc.subjectOvary
dc.subjectOxidative Stress
dc.subjectPlant Extracts
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectUsnea
dc.subjectacetic acid ethyl ester
dc.subjectalanine aminotransferase
dc.subjectaspartate aminotransferase
dc.subjectcreatine kinase MB
dc.subjectcreatinine
dc.subjectglutathione
dc.subjectinterleukin 6
dc.subjectmalonaldehyde
dc.subjectnitrogen
dc.subjectplant extract
dc.subjecttroponin I
dc.titleEffect of ethyl acetate extract from Usnea longissima on chemotherapy-associated multiple organ dysfunction in rats
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus0
rdl.departmentDepartment of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: sevalbulut2010@hotmail.com. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: rmammadov@erzincan.edu.tr. | Department of Physiology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: bcicek@erzincan.edu.tr. | Department of Biochemistry, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: terkmen@erzincan.edu.tr. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: hsuleyman@erzincan.edu.tr.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexPUBMED